Regorafenib

Back to search

Molecule Structure

Scientific Name

Regorafenib

Description of the Drug

Regorafenib is a kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08896

Brand Name(s)

Stivarga

Company Owner(s)

Bayer Healthcare Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tyrosine-protein kinase ABL SINGLE PROTEIN INHIBITOR CHEMBL1862
Discoidin domain-containing receptor 2 SINGLE PROTEIN INHIBITOR CHEMBL5122
Fibroblast growth factor receptor 1 SINGLE PROTEIN INHIBITOR CHEMBL3650
Tyrosine-protein kinase FRK SINGLE PROTEIN INHIBITOR CHEMBL4223
Serine/threonine-protein kinase B-raf SINGLE PROTEIN INHIBITOR CHEMBL5145
Nerve growth factor receptor Trk-A SINGLE PROTEIN INHIBITOR CHEMBL2815
Fibroblast growth factor receptor 2 SINGLE PROTEIN INHIBITOR CHEMBL4142
Tyrosine-protein kinase receptor RET SINGLE PROTEIN INHIBITOR CHEMBL2041
Vascular endothelial growth factor receptor PROTEIN FAMILY INHIBITOR CHEMBL2095227
Ephrin type-A receptor 2 SINGLE PROTEIN INHIBITOR CHEMBL2068
Platelet-derived growth factor receptor PROTEIN COMPLEX INHIBITOR CHEMBL2095189
Serine/threonine-protein kinase RAF SINGLE PROTEIN INHIBITOR CHEMBL1906
Tyrosine-protein kinase TIE-2 SINGLE PROTEIN INHIBITOR CHEMBL4128
Stem cell growth factor receptor SINGLE PROTEIN INHIBITOR CHEMBL1936
MAP kinase p38 beta SINGLE PROTEIN INHIBITOR CHEMBL3961

Unichem Links

SureChEMBL SCHEMBL432230
Human Metabolome Database HMDB0257137
DrugBank DB08896
PubChem: Thomson Pharma 16247148
PubChem 11167602
LINCS LSM-1226
Nikkaji J2.963.976K
BindingDB 50363397
EPA CompTox Dashboard DTXSID60226441
DrugCentral 4654
Brenda 213519
ChemicalBook CB32498792
Guide to Pharmacology 5891
rxnorm STIVARGA REGORAFENIB
PubChem: Drugs of the Future 123055398
ChEBI 68647
ZINC ZINC000006745272